Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › molnupiravir

molnupiravir

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of molnupiravir

6 trials tracked of molnupiravir: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 99 citations.

6Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 2 Phase 2 1 Phase 1 3
  1. Phase 3 Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) Completed · 99 cited
  2. Phase 3 Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013) Completed · 22 cited
  3. Phase 2 Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017) Completed
  4. Phase 1 A Study to Evaluate Molnupiravir (MK-4482; MOV) in Participants With Severe Renal Impairment (MK-4482-003) Completed
  5. Phase 1 Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019) Completed
  6. Phase 1 A Study to Evaluate Molnupiravir (MK-4482) in Participants With Moderate Hepatic Impairment (MK-4482-016) Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
US observational study examines dispensing trends for oral COVID-19 antivirals by zip code and social vulnerability
Infectious Disease
US observational study examines dispensing trends for oral COVID-19 antivirals by zip code and social vulnerability Are COVID-19 treatment pills reaching the communities that need them most?
An observational study in the United States examined trends in dispensing of oral antiviral drugs for COVID-19 treatment by zip code and soc…
A new report maps where COVID-19 antiviral pills are being dispensed across U.S. zip codes to check if areas with higher social vulnerabilit…
CDC Apr 5, 2026
Phase 1 study finds molnupiravir 800 mg well-tolerated with no NHC accumulation in healthy Chinese adults
Infectious Disease Phase I
Phase 1 study finds molnupiravir 800 mg well-tolerated with no NHC accumulation in healthy Chinese adults How does a COVID-19 pill behave in the body? A small study in healthy men offers clues
An open-label, fixed-sequence Phase 1 study in 16 healthy male Chinese adults evaluated the pharmacokinetics and safety of oral molnupiravir…
Understanding how a drug moves through the body is a crucial first step.
Apr 4, 2026